↓ Skip to main content

“To patent or not to patent? the case of Novartis’ cancer drug Glivec in India”

Overview of attention for article published in Globalization and Health, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#21 of 1,245)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news
19 news outlets
blogs
1 blog
policy
1 policy source
twitter
34 X users
facebook
1 Facebook page

Readers on

mendeley
133 Mendeley